Since expression of SphK1 in the triple negative (TN) cancer cell line, MDA-MB-231 was upregulated in stiff substrate in our results, we anticipated that breast cancer cells would increase SphK1 levels in stiff substrates. This evidence concerns the gene SPHK1 and breast cancer.